Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement

Sarcoidosis, a chronic granulomatous disease of unknown etiology, is treated with immune suppressive drugs such as corticosteroids. Sarcoidosis patients have been reported to benefit clinically from treatment with thalidomide. We administered thalidomide for 16 weeks to eight patients with chronic s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.). - 1999. - 102(2002), 3 vom: 22. März, Seite 225-36
1. Verfasser:	Oliver, Stephen J (VerfasserIn)
Weitere Verfasser:	Kikuchi, Toyoko, Krueger, James G, Kaplan, Gilla
Format:	Aufsatz
Sprache:	English
Veröffentlicht:	2002
Zugriff auf das übergeordnete Werk:	Clinical immunology (Orlando, Fla.)
Schlagworte:	Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Antigens, CD Dermatologic Agents HLA-DR Antigens Immunosuppressive Agents Interleukin-2 Tumor Necrosis Factor-alpha Interleukin-12 mehr... 187348-17-0 Thalidomide 4Z8R6ORS6L